Figure 3From: Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritisRadiographic progression (Larsen scores) and anti-CFFCP and anti-CCP2 status in patients with early RA after 2 years of follow-up. *P < 0.01. **P < 0.05.Back to article page
